CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 0.820
  • +0.050+6.49%
15min DelayMarket Closed Apr 29 16:00 ET
71.01MMarket Cap-2.00P/E (TTM)

Oncolytics Biotech Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.52%34.98M
-4.66%8.44M
-10.40%9.9M
10.61%7.92M
29.58%8.73M
25.51%33.79M
4.01%8.85M
82.31%11.05M
18.43%7.16M
6.72%6.73M
Selling and administrative expenses
-17.65%12.91M
-8.63%3.46M
-40.71%3.11M
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
6.20%3.79M
129.19%5.24M
26.06%3.46M
22.79%3.2M
-General and administrative expense
-17.65%12.91M
-8.63%3.46M
-40.71%3.11M
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
6.20%3.79M
129.19%5.24M
26.06%3.46M
22.79%3.2M
Research and development costs
22.24%21.65M
-2.28%4.55M
16.92%6.79M
23.16%4.56M
62.28%5.74M
14.76%17.71M
-3.80%4.66M
57.99%5.81M
15.51%3.7M
-4.56%3.54M
Depreciation amortization depletion
5.21%424K
----
----
----
----
2.81%403K
----
----
----
----
-Depreciation and amortization
5.21%424K
----
----
----
----
2.81%403K
----
----
----
----
Operating profit
-3.52%-34.98M
4.66%-8.44M
10.40%-9.9M
-10.61%-7.92M
-29.58%-8.73M
-25.51%-33.79M
-4.01%-8.85M
-82.31%-11.05M
-18.43%-7.16M
-6.72%-6.73M
Net non-operating interest income (expenses)
-9.58%1.2M
-68.92%152K
-14.43%261K
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
Non-operating interest income
-9.58%1.2M
-68.92%152K
-14.43%261K
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
Other net income (expenses)
-54.20%2.2M
-93.47%291K
-87.03%107K
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
Gain on sale of security
-54.20%2.2M
-93.47%291K
-87.03%107K
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
Income before tax
-14.19%-31.58M
-104.66%-7.99M
3.90%-9.53M
3.15%-7.16M
-7.10%-6.89M
-11.73%-27.66M
54.03%-3.91M
-125.10%-9.92M
-45.84%-7.39M
5.04%-6.44M
Income tax
34.02%130K
-46.51%23K
71.43%12K
102.13%95K
15.48%97K
-24.56%43K
250.00%7K
88.00%47K
Earnings from equity interest net of tax
Net income
-14.26%-31.71M
-103.01%-8.02M
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
Net income continuous operations
-14.26%-31.71M
-103.01%-8.02M
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
Noncontrolling interests
Net income attributable to the company
-14.26%-31.71M
-103.01%-8.02M
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-14.26%-31.71M
-103.01%-8.02M
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
Diluted earnings per share
0.00%-0.41
-100.00%-0.1
14.29%-0.12
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
Basic earnings per share
0.00%-0.41
-100.00%-0.1
14.29%-0.12
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 3.52%34.98M-4.66%8.44M-10.40%9.9M10.61%7.92M29.58%8.73M25.51%33.79M4.01%8.85M82.31%11.05M18.43%7.16M6.72%6.73M
Selling and administrative expenses -17.65%12.91M-8.63%3.46M-40.71%3.11M-2.80%3.36M-6.64%2.98M41.25%15.68M6.20%3.79M129.19%5.24M26.06%3.46M22.79%3.2M
-General and administrative expense -17.65%12.91M-8.63%3.46M-40.71%3.11M-2.80%3.36M-6.64%2.98M41.25%15.68M6.20%3.79M129.19%5.24M26.06%3.46M22.79%3.2M
Research and development costs 22.24%21.65M-2.28%4.55M16.92%6.79M23.16%4.56M62.28%5.74M14.76%17.71M-3.80%4.66M57.99%5.81M15.51%3.7M-4.56%3.54M
Depreciation amortization depletion 5.21%424K----------------2.81%403K----------------
-Depreciation and amortization 5.21%424K----------------2.81%403K----------------
Operating profit -3.52%-34.98M4.66%-8.44M10.40%-9.9M-10.61%-7.92M-29.58%-8.73M-25.51%-33.79M-4.01%-8.85M-82.31%-11.05M-18.43%-7.16M-6.72%-6.73M
Net non-operating interest income (expenses) -9.58%1.2M-68.92%152K-14.43%261K27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K
Non-operating interest income -9.58%1.2M-68.92%152K-14.43%261K27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K
Other net income (expenses) -54.20%2.2M-93.47%291K-87.03%107K183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K
Gain on sale of security -54.20%2.2M-93.47%291K-87.03%107K183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K
Income before tax -14.19%-31.58M-104.66%-7.99M3.90%-9.53M3.15%-7.16M-7.10%-6.89M-11.73%-27.66M54.03%-3.91M-125.10%-9.92M-45.84%-7.39M5.04%-6.44M
Income tax 34.02%130K-46.51%23K71.43%12K102.13%95K15.48%97K-24.56%43K250.00%7K88.00%47K
Earnings from equity interest net of tax
Net income -14.26%-31.71M-103.01%-8.02M3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M
Net income continuous operations -14.26%-31.71M-103.01%-8.02M3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M
Noncontrolling interests
Net income attributable to the company -14.26%-31.71M-103.01%-8.02M3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -14.26%-31.71M-103.01%-8.02M3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M
Diluted earnings per share 0.00%-0.41-100.00%-0.114.29%-0.1216.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.1
Basic earnings per share 0.00%-0.41-100.00%-0.114.29%-0.1216.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.1
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More